Abstract
Epigenetic mechanisms have been recognized to be important for the physiologic regulation of cognitive functions and their pathologic alterations contribute to many neurologic and neuropsychiatric diseases. We survey here an important mechanism of epigenetic regulation of brain function, the histone acetylation state modulated by histone deacetylases (HDACs), and its impact on cognitive behaviour as well as on hippocampal adult neurogenesis, which is presently recognized as an essential process for learning and memory. A potent way to modulate histone acetylation state is through HDAC inhibitors, which are currently tested as potential drugs for treatment of major diseases including cancer and neurologic/neuropsychiatric disorders. Various HDAC inhibitor molecules and their impact on brain function are examined with particular reference to neuroprotective action of some of these substances. The core of the review deals with the current status of the literature on the use of some of these inhibitors as memory enhancers and dementia-fighting agents as well as on their possible role in regulation of adult neurogenesis in the hippocampal dentate gyrus, a process linked to the ability of acquiring new memories. Possible reasons for the many controversial results arising from the literature are discussed in view of establishing a more reliable ground for the future use of HDAC inhibitors to improve memory process in brain health and disease.
Keywords: Epigenetics, Histone acetylation state, Transcription regulation, Memory, Hippocampus, Dentate gyrus, Adult neurogenesis, neuropsychiatric disorders, phenotypical, HISTONE DEACETYLASE, basolateral amygdala, hippocampus-dependent, ameliorated, kinase, astrocytes
Current Psychopharmacology
Title: Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
Volume: 1
Author(s): Antonio Contestabile, Silvia Sintoni and Barbara Monti
Affiliation:
Keywords: Epigenetics, Histone acetylation state, Transcription regulation, Memory, Hippocampus, Dentate gyrus, Adult neurogenesis, neuropsychiatric disorders, phenotypical, HISTONE DEACETYLASE, basolateral amygdala, hippocampus-dependent, ameliorated, kinase, astrocytes
Abstract: Epigenetic mechanisms have been recognized to be important for the physiologic regulation of cognitive functions and their pathologic alterations contribute to many neurologic and neuropsychiatric diseases. We survey here an important mechanism of epigenetic regulation of brain function, the histone acetylation state modulated by histone deacetylases (HDACs), and its impact on cognitive behaviour as well as on hippocampal adult neurogenesis, which is presently recognized as an essential process for learning and memory. A potent way to modulate histone acetylation state is through HDAC inhibitors, which are currently tested as potential drugs for treatment of major diseases including cancer and neurologic/neuropsychiatric disorders. Various HDAC inhibitor molecules and their impact on brain function are examined with particular reference to neuroprotective action of some of these substances. The core of the review deals with the current status of the literature on the use of some of these inhibitors as memory enhancers and dementia-fighting agents as well as on their possible role in regulation of adult neurogenesis in the hippocampal dentate gyrus, a process linked to the ability of acquiring new memories. Possible reasons for the many controversial results arising from the literature are discussed in view of establishing a more reliable ground for the future use of HDAC inhibitors to improve memory process in brain health and disease.
Export Options
About this article
Cite this article as:
Contestabile Antonio, Sintoni Silvia and Monti Barbara, Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis, Current Psychopharmacology 2012; 1 (1) . https://dx.doi.org/10.2174/2211556011201010014
DOI https://dx.doi.org/10.2174/2211556011201010014 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Angiotensin-Receptor Blockers and the Risk of Alzheimer´s Disease: A Meta-analysis
Current Reviews in Clinical and Experimental Pharmacology Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Role of Acetylcholinesterase Inhibitors in the Metabolism of Amyloid Precursor Protein
Current Drug Targets - CNS & Neurological Disorders BELFAST Centenarians: A Case of Optimal Cardiovascular Risk?
Current Pharmaceutical Design Role of Metal Ions in the Aβ Oligomerization in Alzheimers Disease and in Other Neurological Disorders
Current Alzheimer Research Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Rivastigmine for Refractory REM Behavior Disorder in Mild Cognitive Impairment
Current Alzheimer Research MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design The Progress of Epilepsy after Stroke
Current Neuropharmacology Intracompartmental Delivery of CNTF as Therapy for Huntingtons Disease and Retinitis Pigmentosa
Current Gene Therapy Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian Patients
Current Vascular Pharmacology Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach
Current Pharmaceutical Design Heme Oxygenase-1 Dysregulation in the Brain: Implications for HIVAssociated Neurocognitive Disorders
Current HIV Research Beneficial Effects of Bioactive Phospholipids: Genomic Bases
Current Nutrition & Food Science Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?
Current Pharmaceutical Design Genetic Polymorphisms of Type-1 and Type-2 Inflammatory Cytokines in Ischaemic Stroke
Vascular Disease Prevention (Discontinued) The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry